Bb. Holmes et al., HEROIN ACTS ON DELTA-OPIOID RECEPTORS IN THE BRAIN OF STREPTOZOCIN-INDUCED DIABETIC RATS, Proceedings of the Society for Experimental Biology and Medicine, 218(4), 1998, pp. 334-340
Heroin, like morphine, given intracerebroventricularly produces analge
sia by acting on mu opioid receptors in most mice. In contrast, in Swi
ss Webster mice, heroin has the unusual property of acting on brain de
lta opioid receptors whereas morphine still acts on CI receptors, The
literature indicates that in diabetic mice and rats, the CI agonist po
tency of morphine Is diminished while that to a delta receptor agonist
is enhanced. The purpose of the present study was to determine if the
response to heroin occurred through a delta receptor in the brain of
streptozotocin-induced diabetic Sprague-Dawley rats. One week after a
cannula was surgically implanted in the lateral ventricle, diabetes wa
s induced by intravenous administration of 55 mg/kg of streptozotocin,
Three days later the receptor selectivity of intraventricular heroin
in the tail flick test was determined by coadministration of opioid an
tagonists. In nondiabetic rats, a rightward shift in the dose response
curve for heroin was produced by naloxone. D-Phe-Cys-Tyr-D-Trp-Orn-Th
r-Pen-ThrNH(2), a more mu receptor selective antagonist given in a sin
gle dose experiment, also inhibited heroin action. Thus, heroin acted
on mu receptors, In diabetic rats, intracerebroventricular naltrindole
, but not naloxone nor CTOP, inhibited the heroin response and indicat
ed a delta agonist action for heroin. Inhibition by intrathecal yohimb
ine of the mu (nondiabetic) and bicuculline of the delta response (dia
betic) suggested spinal alpha(2)-adrenergic and GABA(A) receptor media
tion, respectively, for the descending systems. In conclusion, the res
ponse to heroin was changed from mu in nondiabetic rats to a delta rec
eptor action in diabetic rats. Understanding the basis for this change
in receptor selectivity of heroin could provide an important avenue f
or investigating determinants of opioid receptor function.